identifeye HEALTH

identifeye HEALTH

AI retinal diagnostics platform for providers

Overview

Identifeye Health builds an AI-powered retinal imaging platform for medical diagnostics. Its system lets healthcare providers—clinics and hospitals—capture retinal images and receive real-time analyses to extract health insights. The platform includes imaging hardware/software and access to AI algorithms, with services and subscriptions for ongoing use. How it works: clinicians or trained staff capture retinal images; the AI analyzes the images instantly to flag potential health issues and provide diagnostic support, enabling earlier detection at point-of-care. How it differs: it targets non-specialists with real-time retinal diagnostics, combining image capture, AI interpretation, and provider-focused services in a single platform, aimed at broad adoption in clinics and hospitals. Its goal: expand access to early, actionable health information from retinal imaging, improving early diagnosis and treatment through scalable AI-enabled diagnostics.

About identifeye HEALTH

Simplify's Rating
Why identifeye HEALTH is rated
C
Rated C on Competitive Edge
Rated B on Growth Potential
Rated D+ on Differentiation

Industries

Enterprise Software

AI & Machine Learning

Healthcare

Company Size

11-50

Company Stage

Series B

Total Funding

$80M

Headquarters

Guilford, Connecticut

Founded

2018

Simplify Jobs

Simplify's Take

What believers are saying

  • AI toolkit expands internationally, targeting high-diabetes regions for subscription growth.
  • Retinal biomarkers detect Alzheimer's, Parkinson's, enabling neurology partnerships.
  • Portable design unlocks revenue from FQHCs and retail pharmacies.

What critics are saying

  • FDA reclassifies identifeye Camera, mandating studies and delaying expansion 6-12 months.
  • Zeiss, Topcon bundle competing systems into EHRs, undercutting primary care entry.
  • CMS denies reimbursement for point-of-care images, stalling provider adoption.

What makes identifeye HEALTH unique

  • identifeye Camera enables non-specialists to capture retinal images portably at point-of-care.
  • AI platform detects diabetic retinopathy, glaucoma, macular degeneration via fundus imaging.
  • identifeye Portal integrates EHR for seamless workflow and teleretinal interpretations.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$80M

Above

Industry Average

Funded Over

1 Rounds

Series B funding is typically for startups that have proven their business model and need more funding to expand rapidly—often by entering new markets or adding more products. Investors are usually venture capital firms that specialize in later-stage investments.
Series B Funding Comparison
Above Average

Industry standards

$35M
$45M
Linktree
$65M
Substack
$80M
 identifeye HEALTH
$100M
ClickUp

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Unlimited Paid Time Off

Hybrid Work Options

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

-2%

1 year growth

0%

2 year growth

8%
Cardiac Vascular News
Apr 29th, 2022
Tesseract Health hires Michael McConnell as Head of Cardiovascular and Digital Health

Tesseract Health, a health technology company developing a portable, non-invasive platform to detect health conditions through the eyes, proudly announces the appointment of Michael McConnell, MD, MSEE, as Tesseract’s Head of Cardiovascular and Digital Health.

Business Wire
Apr 20th, 2021
Tesseract Health Closes Oversubscribed $80 Million Series B Financing

GUILFORD, Conn.--(BUSINESS WIRE)--Tesseract Health Inc. has raised $80 million in an oversubscribed Series B financing round.

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for identifeye HEALTH right now.

Find jobs on Simplify and start your career today

We update identifeye HEALTH's jobs every few hours, so check again soon! Browse all jobs →